2023
DOI: 10.2139/ssrn.4429566
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Targeting HIF1α in Bone Marrow Transplant Allows Combo-Immunotherapy to Boost Graft vs Leukemia Effect Without Exacerbation Graft vs Host Disease

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles